BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34884457)

  • 1. Blood-Brain Barrier in Brain Tumors: Biology and Clinical Relevance.
    Mo F; Pellerino A; Soffietti R; Rudà R
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood-brain barrier and blood-tumour barrier in brain tumours and metastases.
    Arvanitis CD; Ferraro GB; Jain RK
    Nat Rev Cancer; 2020 Jan; 20(1):26-41. PubMed ID: 31601988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.
    Park EJ; Zhang YZ; Vykhodtseva N; McDannold N
    J Control Release; 2012 Nov; 163(3):277-84. PubMed ID: 23000189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of the immune landscape in murine glioblastoma following blood brain/tumor barrier disruption with MR image-guided focused ultrasound.
    Sheybani ND; Witter AR; Garrison WJ; Miller GW; Price RJ; Bullock TNJ
    J Neurooncol; 2022 Jan; 156(1):109-122. PubMed ID: 34734364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
    Arvanitis CD; Askoxylakis V; Guo Y; Datta M; Kloepper J; Ferraro GB; Bernabeu MO; Fukumura D; McDannold N; Jain RK
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8717-E8726. PubMed ID: 30150398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
    Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
    J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical blood-brain barrier disruption induced by focused ultrasound does not overcome the transporter-mediated efflux of erlotinib.
    Goutal S; Gerstenmayer M; Auvity S; Caillé F; Mériaux S; Buvat I; Larrat B; Tournier N
    J Control Release; 2018 Dec; 292():210-220. PubMed ID: 30415015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
    Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
    J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving CNS Delivery to Brain Metastases by Blood-Tumor Barrier Disruption.
    Sprowls SA; Arsiwala TA; Bumgarner JR; Shah N; Lateef SS; Kielkowski BN; Lockman PR
    Trends Cancer; 2019 Aug; 5(8):495-505. PubMed ID: 31421906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
    Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
    Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
    Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
    Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.
    Chen PY; Hsieh HY; Huang CY; Lin CY; Wei KC; Liu HL
    J Transl Med; 2015; 13():93. PubMed ID: 25784614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Era of Immunotherapy in Pediatric Brain Tumors: Chimeric Antigen Receptor T-Cell Therapy.
    Wu WT; Lin WY; Chen YW; Lin CF; Wang HH; Wu SH; Lee YY
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Regulation of Blood-Brain Barrier for Enhanced Therapeutic Efficiency of Hypoxia-Modifier Nanoparticles and Immune Checkpoint Blockade Antibodies for Glioblastoma.
    Meng L; Wang C; Lu Y; Sheng G; Yang L; Wu Z; Xu H; Han C; Lu Y; Han F
    ACS Appl Mater Interfaces; 2021 Mar; 13(10):11657-11671. PubMed ID: 33684289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of thermal therapy on the blood-brain barrier and blood-tumor barrier.
    Patel B; Yang PH; Kim AH
    Int J Hyperthermia; 2020 Jul; 37(2):35-43. PubMed ID: 32672118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The blood-brain barrier: its influence in the treatment of brain tumors metastases.
    Fortin D
    Curr Cancer Drug Targets; 2012 Mar; 12(3):247-59. PubMed ID: 22229251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
    Khaitan D; Reddy PL; Ningaraj N
    Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced delivery of paclitaxel liposomes using focused ultrasound with microbubbles for treating nude mice bearing intracranial glioblastoma xenografts.
    Shen Y; Pi Z; Yan F; Yeh CK; Zeng X; Diao X; Hu Y; Chen S; Chen X; Zheng H
    Int J Nanomedicine; 2017; 12():5613-5629. PubMed ID: 28848341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid based low viscosity hydrogel as a novel carrier for Convection Enhanced Delivery of CAR T cells.
    Atik AF; Suryadevara CM; Schweller RM; West JL; Healy P; Herndon Ii JE; Congdon KL; Sanchez-Perez L; McLendon RE; Archer GE; Fecci P; Sampson JH
    J Clin Neurosci; 2018 Oct; 56():163-168. PubMed ID: 30041899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2
    Priceman SJ; Tilakawardane D; Jeang B; Aguilar B; Murad JP; Park AK; Chang WC; Ostberg JR; Neman J; Jandial R; Portnow J; Forman SJ; Brown CE
    Clin Cancer Res; 2018 Jan; 24(1):95-105. PubMed ID: 29061641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.